|
Founded in 1995, the AIDS Vaccine Advocacy Coalition (AVAC) is a non-profit, community- and consumer-based organization that uses public education, policy analysis, advocacy and community mobilization to accelerate the ethical development and global delivery of AIDS vaccines and other HIV prevention options.
-------------------------------------------------------------------------------------------------------------------------
HVTN 505 vaccine trial update and teleconferences
Click here to read AVAC's recent Advocates' Network update on HVTN 505
-------------------------------------------------------------------------------------------------------------------------
Cutting through the news: Understanding recent reports on male circumcision
Click here for AVAC's coverage of recent news stories and scientific publications about male circumcision for HIV prevention including information on what's known--and what remains unknown--about the relationship between circumcision status and risk of HIV infection in gay men and other men who have sex with men (MSM).
-------------------------------------------------------------------------------------------------------------------------
Px Wire
PAVE 100 trial update, women weigh in on male circumcision for prevention, Mexico City debrief, new trials map and more all available in the newest edition of Px Wire--now available to download!
Download the current issue of Px Wire: A Quarterly Update on HIV Prevention Research
-------------------------------------------------------------------------------------------------------------------------
PrEP Advocacy Update
Over the past several months AVAC and its partners have been ramping up efforts to expand the pre-exposure prophylaxis (PrEP) for HIV prevention agenda. Activities include a new report on the state of PrEP research and advocacy priorities for the months ahead, and a dynamic satellite session on PrEP that took place in Mexico City at the International AIDS Conference. Click the links below for more:
Download the meeting report from AVAC's satellite session, "Expecting (and managing) the unexpected: Reality check for PrEP and other new prevention options"
Download AVAC's new report on PrEP (pre-exposure prophylaxis), "Anticipating the Results of PrEP Trials: A powerful new HIV prevention tool may be on the horizon. Are we prepared?"
Download AVAC's recent Advocates' Network update on PrEP
-------------------------------------------------------------------------------------------------------------------------
Click here for the "What's New" archive
AVAC's publications and continuous policy, advocacy, education and outreach work is made possible by the dedicated labor of AVAC advocates and support from Broadway Cares/Equity Fights AIDS, the Ford Foundation, the Bill &
Melinda Gates Foundation, the Global HIV Vaccine Enterprise, the International AIDS Vaccine Initiative, the International Partnership for Microbicides, Until There's a Cure Foundation®, the WHO-UNAIDS HIV Vaccine Initiative, UNAIDS, and many generous individuals who have become AVAC Members.
Website Copyright 2006 AIDS Vaccine Advocacy Coalition / Site Design: Canfield Design Studios, Inc.
|
